Aligos Therapeutics, Inc. Shares Outstanding
Aligos Therapeutics, Inc. (ALGS) had Shares Outstanding of 6.24 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 6.24M shares; Shares authorized (split-adjusted) 115.80M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 6.19M shares; Shares authorized (split-adjusted) 115.80M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 6.18M shares; Shares authorized (split-adjusted) 115.80M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 6.15M shares; Shares authorized (split-adjusted) 115.80M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 6.24M shares 10-Q · filed 2026-08-06 | 115.80M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 6.19M shares 10-Q · filed 2026-05-07 | 115.80M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 6.18M shares 10-Q · filed 2026-08-06 | 115.80M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 6.15M shares 10-Q · filed 2025-11-06 | 115.80M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 6.15M shares 10-Q · filed 2025-08-06 | 115.80M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 6.11M shares 10-Q · filed 2025-05-06 | 20.80M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 3.86M shares 10-K · filed 2026-03-05 | 20.80M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 3.32M shares 10-Q · filed 2024-11-06 | 20.80M shares 10-Q · filed 2024-11-06 |
| 2024-08-19 | 79.90M shares 10-K · filed 2026-03-05 | (m) |
| 2024-06-30 | 79.79M shares 10-Q · filed 2024-08-06 | 520.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 75.67M shares 10-Q · filed 2024-05-07 | 320.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 3.00M shares 10-K · filed 2025-03-10 | 12.80M shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 43.50M shares 10-Q · filed 2023-11-02 | 320.00M shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 43.50M shares 10-Q · filed 2023-08-03 | 320.00M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 42.94M shares 10-Q · filed 2023-05-04 | 320.00M shares 10-Q · filed 2023-05-04 |
| 2022-12-31 | 42.92M shares 10-K · filed 2024-03-12 | 320.00M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 42.82M shares 10-Q · filed 2022-11-02 | 320.00M shares 10-Q · filed 2022-11-02 |
| 2022-06-30 | 42.81M shares 10-Q · filed 2022-08-04 | 320.00M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 42.70M shares 10-Q · filed 2022-05-04 | 320.00M shares 10-Q · filed 2022-05-04 |
| 2021-12-31 | 42.69M shares 10-K · filed 2023-03-09 | 320.00M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 42.61M shares 10-Q · filed 2021-11-04 | 320.00M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 38.20M shares 10-Q · filed 2021-08-05 | 320.00M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 38.15M shares 10-Q · filed 2021-05-10 | 320.00M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 38.12M shares 10-K · filed 2022-03-10 | 320.00M shares 10-K · filed 2022-03-10 |
| 2020-10-20 | (m) | 12.80M shares 10-K · filed 2026-03-05 |
| 2020-09-30 | 4.10M shares 10-Q · filed 2020-11-25 | 278.00M shares 10-Q · filed 2020-11-25 |
| 2019-12-31 | 3.93M shares 10-K · filed 2021-03-23 | 278.00M shares 10-K · filed 2021-03-23 |
| 2019-12-23 | (m) | 278.00M shares 10-K · filed 2021-03-23 |
| 2018-08-15 | (m) | 149.00M shares 10-K · filed 2021-03-23 |
| 2018-07-23 | (m) | 25.00M shares 10-K · filed 2021-03-23 |
| 2018-02-05 | (m) | 20.00M shares 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |